U.S.-China Trade Policy and the Pharmaceutical Industry
U.S. Drugmakers are raising alarms with the White House over potential market disruption due to Trump's proposed anti-China measures, revealing intense lobbying efforts from pharmaceutical companies and influential billionaires.